Mix-and-match trial finds additional dose of COVID-19 vaccine safe, immunogenic
National Institutes of Health (NIH) sent this bulletin at 01/26/2022 05:30 PM ESTHaving trouble viewing this email? View it as a Web page.
You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH).
01/26/2022 05:00 PM EST
NIH-sponsored study assessed dose in adults fully vaccinated with any EUA or approved COVID-19 vaccine